Moxit Shah , DM Endocrinology, provides comprehensive care for obesity and metabolic health
Additionally, the length of treatment and the probability of relapse needs to be established before the regulatory approval of these drugs for addiction
Common Side Effects Nausea (most common, peaks during dose escalation) Diarrhea, constipation, vomiting Decreased appetite, fatigue, headache Injection-site reactions (injectable forms) Rare: pancreatitis, gallbladder disease, kidney injury FDA boxed warning for medullary thyroid carcinoma (do not use with personal or family history of MTC or MEN2) How to Start GLP-1 Treatment See a clinician in-person primary care, endocrinology, obesity medicine, or US telehealth
(2019) 6:e565
DOI: Published: Publisher Name: Springer, Cham Print ISBN: 978-3-031-31757-6 Online ISBN: 978-3-031-31758-3 eBook Packages: MedicineMedicine (R0)